Our research department was created to become involved
in the advancement of new treatments and
procedures in the field of dermatology.
Our mission is to be on the front lines of dermatologic research to evaluate the science and support the development of ground breaking novel treatments. We have state of the art facilities equipped with advanced treatment devices, photography equipment, CLIA certified labs, secure storage locations, HIPAA compliant patient database (over 500,000), and highly experienced staff. With the expansion of our dedicated research center at 1730 Minor Ave Floor 10, Dermatology Associates of Seattle devotes an increased effort towards expanding research activities.
Clinical Research Resources
Dermatology Associates of Seattle's research network believes in fully informing their research patients with both clinical research options and solutions. If any of your questions were not answered using the information contained in this
website, you can contact us at anytime in the form below.
Below is a list of free informational websites to learn more about clinical research:
Qualified study participants will receive no-cost study related care, investigational study medication and compensation for time and travel. New trials are always coming please contact us to learn about future studies.
Corrona Psoriasis Registry
Patients need or have been diagnosed with psoriasis by a dermatologist and starting or currently using a biologic for psoriasis
(e.g. Humira, Enbrel, Tremfya, Cosentyx, or Stelara).
Psoriasis (Lilly Oasis-2)
Patients should be 18 years or older and diagnosed with moderate to severe chronic plaque psoriasis for at least 6 months.
Psoriasis (BMS IM011046)
Patients should be 18 years or older and diagnosed with moderate to severe plaque psoriasis for at least 6 months. Patients should also be candidates for phototherapy or systemic therapy.
Patients should be 12-65 years old and diagnosed with primary axillary hyperhidrosis.
Patients should be 12 years or older and diagnosed with moderate to severe atopic dermatitis for one year with a minimum body weight of 40kg.
Patients should be male 18-60 years old or female 18-70 years old and have severe alopecia areata.
Hidradenitis Supperativa (HS)
Patients should be 18 years or older and have been diagnosed with moderate to severe hidradenitis supperativa in at least two distinct anatomic areas.